Vericel makes cell therapies and biologic products for knee cartilage repair and severe burn care. VCEL reports earnings on Thu, Nov 5, 2026.
Prices, price targets and earnings estimates for VCEL are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
No whale options trades in VCEL in the last 90 days.
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VCEL is in one of them and how their past VCEL trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Vericel
Vericel is a company in Burlington, Massachusetts that makes cell therapy and specialty biologic products for sports medicine and severe burn care. Its MACI product is an implant made from a patient's own cells that orthopedic surgeons use to repair knee cartilage. Epicel is a permanent skin replacement for severe burns, and NexoBrid is a product applied to burns to remove damaged tissue. Its customers include orthopedic surgeons and burn centers in the United States.
